Boston Scientific Corp (BSX): Capital Expenditures
$876.00M
Year ended 2025-12-31
$904.00M
Trailing 12 months to 2026-06-30
+14.2%
3-year compound annual growth
+18.4%
5-year compound annual growth
+13.5%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $876.00M | +10.9% | 2026-02-17, From 2025-01-01 |
| 2024-12-31 | $790.00M | +11.1% | 2026-02-17, From 2024-01-01 |
| 2023-12-31 | $711.00M | +20.9% | 2026-02-17, From 2023-01-01 |
| 2022-12-31 | $588.00M | +6.1% | 2025-02-18, From 2022-01-01 |
| 2021-12-31 | $554.00M | +47.3% | 2024-02-20, From 2021-01-01 |
| 2020-12-31 | $376.00M | -18.4% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $461.00M | +45.9% | 2022-02-23, From 2019-01-01 |
| 2018-12-31 | $316.00M | -0.9% | 2021-02-23, From 2018-01-01 |
| 2017-12-31 | $319.00M | -15.2% | 2020-02-25, From 2017-01-01 |
| 2016-12-31 | $376.00M | +52.2% | 2019-02-19, From 2016-01-01 |
| 2015-12-31 | $247.00M | -4.6% | 2018-02-20, From 2015-01-01 |
| 2014-12-31 | $259.00M | +5.7% | 2017-02-23, From 2014-01-01 |
| 2013-12-31 | $245.00M | +8.4% | 2016-02-24, From 2013-01-01 |
| 2012-12-31 | $226.00M | -25.7% | 2015-02-25, From 2012-01-01 |
| 2011-12-31 | $304.00M | +11.8% | 2014-02-26, From 2011-01-01 |
| 2010-12-31 | $272.00M | -12.8% | 2013-02-22, From 2010-01-01 |
| 2009-12-31 | $312.00M | -13.8% | 2012-02-17, From 2009-01-01 |
| 2008-12-31 | $362.00M | -0.3% | 2011-02-17, From 2008-01-01 |
| 2007-12-31 | $363.00M | n/a | 2010-02-26, From 2007-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Boston Scientific Corp (BSX) | 2025-12-31 | $876.00M | +10.9% |
| Becton Dickinson & Co (BDX) | 2025-09-30 | $760.00M | +4.8% |
| 3M Co (MMM) | 2025-12-31 | $910.00M | -22.9% |
| Stryker Corp (SYK) | 2025-12-31 | $761.00M | +0.8% |
| Medline Inc. (MDLN) | 2025-12-31 | $447.00M | +26.3% |
| Baxter International Inc (BAX) | 2025-12-31 | $513.00M | +15.0% |
| Solventum Corp (SOLV) | 2025-12-31 | $379.00M | -0.3% |
| ResMed Inc (RMD) | 2026-06-30 | $156.28M | +73.9% |
| Dexcom Inc (DXCM) | 2025-12-31 | $363.50M | +1.3% |
Compare BSX, BDX, MMM, SYK side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗